Atlas Trials

Inhaled Nitric Oxide for Pulmonary Hypertension and Bronchopulmonary Dysplasia

Clinical trial NCT03576885 · TERMINATED

Trial details

NCT number
NCT03576885
Sponsor
AdventHealth
Status
TERMINATED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Pulmonary HypertensionBronchopulmonary Dysplasia
Start date
2019-07-15
Primary completion
2023-10-09
Enrollment
32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.